An artificial intelligence-enabled electrocardiography (ECG) algorithm can predict atrial fibrillation up to 10 years before clinical diagnosis, according to a study conducted by Mayo Clinic researchers.
Atrial fibrillation, the most common cardiac rhythm abnormality, has been linked to one-third of ischemic strokes, the most common type of stroke.
But atrial fibrillation is under-diagnosed, partly because many patients are asymptomatic.
A new population-based study from Mayo Clinic now offers evidence that an algorithm can help to identify patients at greater risk of cognitive decline.
The study is described in an article, ‘Artificial Intelligence-Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts’, published in Mayo Clinic Proceedings.
AI-enabled ECG that shows high probability of atrial fibrillation, was also associated with the presence of cerebral infarctions – death of tissue from a failure of blood supply – on MRI, according to the study.
Most of the infarctions observed were subcortical, meaning that they occurred in the region of the brain below the cortex.
This suggests that AI-enabled ECG not only predicts atrial fibrillation, but also detects other cardiac disease markers and correlates with small vessel cerebrovascular disease and cognitive decline.
“This study finds that artificial intelligence-enabled electrocardiography acquired during normal sinus rhythm was associated with worse baseline cognition and gradual decline in global cognition and attention,” says Jonathan Graff-Radford, a Mayo Clinic neurologist and the study’s corresponding author.
“The findings raise the question whether initiation of anticoagulation is an effective and safe preventive strategy in individuals with a high AI-ECG algorithm score for reducing the risk of stroke and cognitive decline.”
Prospective controlled studies are needed to determine whether a high atrial fibrillation score on an AI-enabled electrocardiogram could be a biomarker to identify patients for anticoagulation or more aggressive stroke risk factor modification, Dr Graff-Radford said.
The retrospective study reviewed sinus-rhythm ECG of 3,729 patients with a median age of 74 years who were enrolled in the Mayo Clinic Study of Aging between 2004 and 2020.
Adjusting for demographic factors, the AI-enabled ECG atrial fibrillation score correlated with lower baseline and faster decline in global cognitive scores.
About one-third of the patients who underwent ECG also had an MRI, and high atrial fibrillation probability in the ECG correlated with MRI-detected cerebral infarcts.
“Application of this AI-ECG algorithm may be another way to screen individuals not only to determine risk of atrial fibrillation, but also to identify future risk of cognitive decline and stroke,” said Dr Graff-Radford.
Research reported in the article was supported by grants from the National Institute on Aging and the National Institutes of Health.
The study was made possible by the Rochester Epidemiology Project.
Potential competing interests are identified in the article. Among the potential competing interests, Peter Noseworthy, a Mayo Clinic cardiologist, and Mayo Clinic have filed patents related to the application of AI to ECG for diagnosis and risk stratification.
